Training cover

Overview of new 2021 ATS Clinical Practice Guidelines: Use of Fractional Exhaled Nitric Oxide (FeNO) to Guide the Treatment of Asthma


Free


Diffusion

Online

Vyaire Medical

4.6

· 4413 Reviews

See the catalog
About Speakers Audience Reviews

About

600 seats per session

English

Asthma is a heterogenous disease. Treatment decisions are typically based on measures of airflow obstruction, the frequency of daytime and nighttime symptoms, and the frequency of exacerbations. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. The new ATS Clinical Practice Guidelines provide evidence-based clinical guidance on whether FeNO testing is indicated to optimize asthma treatment in patients with asthma in whom treatment is being considered. During this webinar, Dr. Philip Silkoff, will review, which questions about FeNO where considered by the ATS committee, the principal findings of the data review and the implication of FeNO testing for the asthma care.


This program has been approved for 1.00 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425, N. MacArthur Blvd, Suite 100, Irving TX 75063


picture

Pulmonologists, PFT specialists, Pulmonary therapists

Speakers icon

Speakers

Speaker Avatar
Dr. Philip Silkoff Senior clinical trial executive
Target audience icon

Audience

This event is for specialists below

Pulmonology

Biomedical technician

Reviews icon

What you peers think about Vyaire Medical

03/02/2022

Deborah H.

5


03/02/2022

Kaylee U.

5


03/02/2022

Alison E.

3.75


03/02/2022

Ann B.

5

Extremely informative and helpful.


03/02/2022

Danielle R.

5


03/02/2022

Connie D.

5

Very informational. We’ll presented.

Contact icon

Contact us

Chat with us

- Chat available in the bottom left corner